Speaker

Scott Hensley
Director, NIH-sponsored Penn Center of Excellence for Influenza Research and Response
Professor of Microbiology, University of Pennsylvania

Title: ”Development of a multivalent mRNA influenza vaccine to replace original antigenic sin with initial blessings of induced immunity”

The Hensley laboratory studies mechanisms that promote antigenic drift of influenza viruses and factors that influence influenza vaccine responsiveness. The Hensley laboratory has developed new RNA-based vaccines to elicit broad immune responses against influenza viruses, and more recently has completed studies to characterize immune responses elicited by SARS-CoV-2 vaccinations and infections.

Join Zoom Meeting
https://pennmedicine.zoom.us/j/93648438798?pwd=WWNqNDJwbFhLOWhjcHBmd094SVFjQT09

The Penn Institute for RNA Innovation Seminar Series is designed for speakers with varying backgrounds to highlight the translational research opportunities of mRNA in their respective field and beyond. Presentations typically last 1 hour.

Pizza, beer, and conversation to follow!